Terry L. Evans - 28 Mar 2026 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Reporting relationship: Chief Commercial Officer
Issuer ticker: FENC
Reported as of: 28 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2026, 16:05:13 UTC
Prior SEC filing: 03 Apr 2025
Next SEC filing: 01 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Terry Evans

Key filing fact

Terry L. Evans filed Form 4 for FENNEC PHARMACEUTICALS INC. (FENC) on 02 Apr 2026.

Key facts

This page summarizes Terry L. Evans's Form 4 filing for FENNEC PHARMACEUTICALS INC. (FENC).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Apr 2026, 16:05.

Change

Previous filing in this sequence was filed on 03 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002043317 Primary reporting owner

Evans Terry L

Relationship: Chief Commercial Officer
Address: C/O FENNEC PHARMACEUTICALS, INC., PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK
Signature: /s/ Terry Evans
Signature date: 02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FENC transaction

Common Shares

Options Exercise

Transaction value
Shares: +18,456
Change %
Price: $0.000000^*
Shares after: 18,456
Date: 31 Mar 2026
Ownership: Direct
Footnotes: F1

FENC transaction

Common shares

Options Exercise

Transaction value
Shares: +171
Change %: +0.93%
Price: $0.000000^*
Shares after: 18,627
Date: 31 Mar 2026
Ownership: Direct
Footnotes: F2

FENC transaction

Common shares

Options Exercise

Transaction value
Shares: +2,052
Change %: +11%
Price: $0.000000^*
Shares after: 20,679
Date: 28 Mar 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FENC transaction Derivative

Stock Options

Award

Transaction value
Shares: +120,000
Change %: +80%
Price: $5.77^*
Shares after: 270,000
Date: 31 Mar 2026
Ownership: Direct
Underlying class: Common Shares
Underlying amount: 120,000
Exercise price: $5.77
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents settlement of PSUs that vested on March 31, 2026.

Footnote F2

Represents shares released from restriction from shares awarded 3/28/2025.

Footnote F3

On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

Footnote F4

One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.